The PGY1 Pharmacy Residency conducted by Denver Health in Denver, Colorado, is accredited by ASHP.
PGY1 residency programs build upon Doctor of Pharmacy (PharmD) education and outcomes to develop pharmacist practitioners with knowledge, skills, and abilities as defined in the educational competency areas, goals, and objectives. Residents who successfully complete PGY1 residency programs will be skilled in diverse patient care, practice management, leadership, and education, and be prepared to provide patient care, seek board certification in pharmacotherapy (i.e., BCPS), and pursue advanced education and training opportunities including postgraduate year two (PGY2) residencies.
The program is a 12-month postgraduate curriculum that offers training opportunities in acute care, ambulatory clinical care, drug use policy development, clinical services, and pharmacy leadership.
The program includes 7 required learning experiences (4 to 6 weeks in length) and a choice of 3 elective learning experiences (4 to 5 weeks in length). There are 5 required longitudinal learning experiences.
Required Learning Experiences (4-5 weeks each)
- Orientation
- Internal Medicine
- Critical Care – choice of Medical ICU or Surgical ICU
- Maternal Child Health / Pediatrics
- Infectious Diseases
- Ambulatory Care
- Medication Safety, Regulatory and Quality
Longitudinal Learning Experiences
- Formulary Management / Drug Policy (3-4 months)
- Service Commitment / Operational Knowledge/Staffing (every 3rd weekend)
- Leadership Development
- Research
- Teaching (including an optional teaching certificate program)
Elective Learning Experiences (4-5 weeks each)
- Ambulatory Care (primary care or geriatrics)
- Behavioral Health
- Clinical Toxicology
- Emergency Medicine
- Critical Care Days (medical or surgical ICU)
- Critical Care Evenings (all critical care areas)
- Neurosurgery
- Oncology/Hematology
- Pediatrics
- Substance Use Disorders
- Teaching Certificate (longitudinal) through The University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
- Any required learning experience may also be taken as an elective
- Opportunities to create new or off-site learning experiences around the resident’s interest (limited to 1 off-site learning experience per year)
PGY1 Pharmacy Residency Research Requirements
- Major Project (presented at Residency Conference of the Rockies)
- Medication Use Evaluation (presented at Vizient and ASHP Midyear poster sessions)
Attendance and participation in the following events:
- Vizient and ASHP Midyear poster session (December)
- ASHP Midyear residency showcase (December)
- Recruitment and interview process
- Regional residency conference (May/June)
- Participation and completion of the RESULTS (Residents Establishing Skills Utilizing Learning and Team Support) Research Certification Program
- LEAN training through the Organizational Development department at Denver Health
Application Information
Applicants must be a PharmD graduate or candidate for graduation of an Accreditation Council for Pharmacy Education (ACPE) accredited degree program and licensed and in good standing, or eligible for licensure, in the state of Colorado by September 1st of the starting year. If not licensed by November 1st, the resident will be terminated from the program.
Denver Health participates in the ASHP National Matching System. Applications should be submitted electronically through PhORCAS. All materials must be received by the application deadline to be considered for the residency program. Necessary application materials include:
- Letter of intent that helps us get to know you beyond your CV (maximum of 2 pages) highlighting the following:
- Your goals and reason for doing a PGY1 Residency
- Why you chose to apply for the Denver Health residency program
- Your strengths and weakness at this point in career and how residency will help you develop and achieve your goals
- Three letters of reference using the PhORCAS Standardized Reference Template. Letter writers should be able to provide unique perspectives, therefore we request that each one be chosen based on their ability to satisfy the following requirements. If one writer is able to speak from two perspectives, they may be used for both, allowing you to choose a third writer of any relationship.
- A preceptor able to speak to your clinical performance (i.e. clinical, problem solving, communication, and patient care skills)
- An employer or someone able to speak to your skills as an employee (i.e. timeliness, customer service, teamwork, etc.)
- A professional contact who has known you for over half of your pharmacy education who can speak to your character and performance over time
- Curriculum Vitae.
- Official college of pharmacy transcript (need not include the current fall semester if unavailable prior to the application deadline).
All completed applications will be reviewed by the Residency Advisory Committee to determine which candidates will be invited for an interview.
Resident applicants are responsible for submitting all required materials online through PhORCAS.
ASHP Code: 82101
NMS#: 134213
Current PGY1 Resident Class :Holly Green, PharmD (2023-2024) Major Project: Intravenous (IV) insulin vs subcutaneous (SQ) insulin for adults with mild – moderate diabetic ketoacidosis (DKA) MUE: Metoprolol rate control dosing for atrial tachyarrhythmia
Marcus Hayner, PharmD (2023-2024) Major Project: HCV treatment management by clinical pharmacist specialist as compared to provider care MUE: Rapid rituximab infusion protocol
Lauren Steil, PharmD (2023-2024) Major Project: Outcomes of a neonatal gentamicin pharmacy to dose program in a level III NICU MUE: IVIG in GAS necrotizing fasciitis with vasopressor dependent shock
Liv Swonger, PharmD (2023-2024) Major Project: Etomidate and adrenal suppression in pediatrics MUE: ACLS in hypothermia |
Contact:Becky Reiss, PharmD, BCPP (she/her) |